 |
 |
 |
|
Efficacy and Safety of Raltegravir Among Latin American Patients in STARTMRK
|
|
|
Reported by Jules Levin
ICAAC 2013 Sept 10-13 Denver, CO
Mauro Schechter1, Juan Sierra-Madero2, Carlos Beltran3, Jose V. Madruga4, Kim Strohmaier5, Anthony Rodgers5, Hedy Teppler5, Randi Leavitt5, Peter Sklar5
1Univ. Federal do Rio de Janeiro, Rio de Janeiro, Brazil; 2Inst. Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico; 3Hosp. Barros Luco Trudeau, Santiago, Chile; 4Centro de Referencia e Treinamento DST/AIDS, Sao Paulo, Brazil; 5Merck, Whitehouse Station, NJ







|
|
|
 |
 |
|
|